BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities

Chih Bo Hu, Ching Ping Chen, Teng Kuang Yeh, Jen Shin Song, Chi Yen Chang, Jiunn Jye Chuu, Fei Feng Tung, Pei Yin Ho, Tung Wei Chen, Chi Hung Lin, Min Hsien Wang, Kai Yen Chang, Chen Lung Huang, Heng Liang Lin, Wen Tai Li, Der Ren Hwang, Jyh Haur Chern, Ling Ling Hwang, Jang Yang Chang, Yu Sheng ChaoChiung Tong Chen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities'. Together they form a unique fingerprint.

Medicine & Life Sciences